keyword
https://read.qxmd.com/read/38645317/simple-and-rapid-method-of-microwell-array-fabrication-for-drug-testing-on-3d-cancer-spheroids
#21
JOURNAL ARTICLE
Mai Anh Nguyen, Nhung Thi Dinh, My Hanh Do Thi, Dung Nguyen Thi, Uyen Thu Pham, Toan Quoc Tran, Vuong Minh Nguyen, Nhung Hong Le, Duong Thanh Nguyen, Dung Thuy Nguyen Pham
Three-dimensional (3D) cell culture systems are becoming increasingly popular due to their ability to mimic the complex process of angiogenesis in cancer, providing more accurate and physiologically relevant data than traditional two-dimensional (2D) cell culture systems. Microwell systems are particularly useful in this context as they provide a microenvironment that more closely resembles the in vivo environment than traditional microwells. Poly(ethylene glycol) (PEG) microwells are particularly advantageous due to their bio-inertness and the ability to tailor their material characteristics depending on the PEG molecular weight...
April 16, 2024: ACS Omega
https://read.qxmd.com/read/38645276/restoring-cellular-copper-homeostasis-in-alzheimer-disease-a-novel-peptide-shuttle-is-internalized-by-an-atp-dependent-endocytosis-pathway-involving-rab5-and-rab14-endosomes
#22
JOURNAL ARTICLE
Michael Okafor, Olivia Champomier, Laurent Raibaut, Sebahat Ozkan, Naima El Kholti, Stéphane Ory, Sylvette Chasserot-Golaz, Stéphane Gasman, Christelle Hureau, Peter Faller, Nicolas Vitale
CPPs, or Cell-Penetrating Peptides, offer invaluable utility in disease treatment due to their ability to transport various therapeutic molecules across cellular membranes. Their unique characteristics, such as biocompatibility and low immunogenicity, make them ideal candidates for delivering drugs, genes, or imaging agents directly into cells. This targeted delivery enhances treatment efficacy while minimizing systemic side effects. CPPs exhibit versatility, crossing biological barriers and reaching intracellular targets that conventional drugs struggle to access...
2024: Frontiers in Molecular Biosciences
https://read.qxmd.com/read/38645142/bioisosteric-analogs-of-mdma-with-improved-pharmacological-profile
#23
Ana Sofia Alberto-Silva, Selina Hemmer, Hailey A Bock, Leticia Alves da Silva, Kenneth R Scott, Nina Kastner, Manan Bhatt, Marco Niello, Kathrin Jäntsch, Oliver Kudlacek, Elena Bossi, Thomas Stockner, Markus R Meyer, John D McCorvy, Simon D Brandt, Pierce Kavanagh, Harald H Sitte
3,4-Methylenedioxymethamphetamine (MDMA, ' ecstasy' ) is re-emerging in clinical settings as a candidate for the treatment of specific psychiatric disorders (e.g. post-traumatic stress disorder) in combination with psychotherapy. MDMA is a psychoactive drug, typically regarded as an empathogen or entactogen, which leads to transporter-mediated monoamine release. Despite its therapeutic potential, MDMA can induce dose-, individual-, and context-dependent untoward effects outside safe settings. In this study, we investigated whether three new methylenedioxy bioisosteres of MDMA improve its off-target profile...
April 11, 2024: bioRxiv
https://read.qxmd.com/read/38645087/mocetinostat-as-a-novel-selective-histone-deacetylase-hdac-inhibitor-in-the-promotion-of-apoptosis-in-glioblastoma-cell-line-c6-and-t98g
#24
Firas Khathayer, Mohammed Mikael
Histon deacetylase (HDAC) enzyme is one of the enzymes involved in regulating gene expression and epigenetic alternation of cells by removing acetyl groups from lysine residue on a histone, allowing the histones to wrap the DNA more tightly and suppressing a tumor-suppressing gene. HDAC inhibitors play an important role in inhibiting the proliferation of tumor cells by restricting the mechanism of action of HDAC enzyme, leading to the addition of acetyl groups to lysine. Mocetinostat, also known by its chemical name (MGCD0103), is a novel isotype selective HDAC enzyme that explicitly targets HDAC isoforms inhibiting Class1(HDAC 1,2,3,8) and Class IV (HDAC11) enzymes...
April 1, 2024: Research Square
https://read.qxmd.com/read/38645018/a-heterogeneous-pharmaco-transcriptomic-landscape-induced-by-targeting-a-single-oncogenic-kinase
#25
Ross M Giglio, Nicholas Hou, Adeya Wyatt, Justin Hong, Lingting Shi, Mathini Vaikunthan, Henry Fuchs, Jose Pomarino Nima, Seth W Malinowski, Keith L Ligon, José R McFaline-Figueroa, Nir Yosef, Elham Azizi, José L McFaline-Figueroa
UNLABELLED: Over-activation of the epidermal growth factor receptor (EGFR) is a hallmark of glioblastoma. However, EGFR-targeted therapies have led to minimal clinical response. While delivery of EGFR inhibitors (EGFRis) to the brain constitutes a major challenge, how additional drug-specific features alter efficacy remains poorly understood. We apply highly multiplex single-cell chemical genomics to define the molecular response of glioblastoma to EGFRis. Using a deep generative framework, we identify shared and drug-specific transcriptional programs that group EGFRis into distinct molecular classes...
April 10, 2024: bioRxiv
https://read.qxmd.com/read/38644836/pan-cancer-analysis-of-polo-like-kinase-family-genes-reveals-polo-like-kinase-1-as-a-novel-oncogene-in-kidney-renal-papillary-cell-carcinoma
#26
JOURNAL ARTICLE
Guo Zhao, Yuning Wang, Jiawei Zhou, Peiwen Ma, Shuhang Wang, Ning Li
BACKGROUND: Polo-like kinases (PLKs) are a kinase class of serine/threonine with five members that play crucial roles in cell cycle regulation. However, their biological functions, regulation, and expression remain unclear. This study revealed the molecular properties, oncogenic role, and clinical significance of PLK genes in pan-cancers, particularly in kidney renal papillary cell carcinoma (KIRP). METHODS: We evaluated the mutation landscape, expression level, and prognostic values of PLK genes using bioinformatics analyses and explored the association between the expression level of PLK genes and tumor microenvironment (TME), immune subtype, cancer immunotherapy, tumor stemness, and drug sensitivity...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38644835/identification-and-validation-of-a-glycosyltransferase-gene-signature-as-a-novel-prognostic-model-for-lung-adenocarcinoma
#27
JOURNAL ARTICLE
Jiejun Zhou, Kun Zhang, Tian Yang, Anqi Li, Meng Li, Xiaojing Peng, Mingwei Chen
BACKGROUND: The role of glycosyltransferase (GT) genes in lung adenocarcinoma (LUAD) needs further elucidation. Thus, our study aims to identify the prognostic gene signature of LUAD and explore its molecular functions. METHODS: We initially extracted GT gene sets from the database, and obtained mRNA expression levels and clinical data from The Cancer Genome Atlas (TCGA) database. For constructing a prognostic model for GT genes, we utilized univariate, least absolute shrinkage and selection operator (LASSO), and multivariate Cox regression analyses...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38644825/network-pharmacology-based-approach-to-elucidate-the-pharmacologic-mechanisms-of-natural-compounds-from-dictyostelium-discoideum-for-alzheimer-s-disease-treatment
#28
JOURNAL ARTICLE
Nil Patil, Rupal Dhariwal, Arifullah Mohammed, Lee Seong Wei, Mukul Jain
Alzheimer's disease (AD) is increasingly becoming a major public health concern in our society. While many studies have explored the use of natural polyketides, alkaloids, and other chemical components in AD treatment, there is an urgent need to clarify the concept of multi-target treatment for AD. This study focuses on using network pharmacology approach to elucidate how secondary metabolites from Dictyostelium discoideum affect AD through multi-target or indirect mechanisms. The secondary metabolites produced by D...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38644797/frahmt-a-fragment-oriented-heterogeneous-graph-molecular-generation-model-for-target-proteins
#29
JOURNAL ARTICLE
Shuang Wang, Dingming Liang, Jianmin Wang, Kaiyu Dong, Yunjing Zhang, Huicong Liang, Ximing Xu, Tao Song
The molecular generation task stands as a pivotal step in the domains of computational chemistry and drug discovery, aiming to computationally generate molecular structures for specific properties. In contrast to previous models that focused primarily on SMILES strings or molecular graphs, our model placed a special emphasis on the substructure information on molecules, enabling the model to learn richer chemical rules and structure features from fragments and chemical reaction information on molecules. To accomplish this, we fragmented the molecules to construct heterogeneous graph representations based on atom and fragment information...
April 22, 2024: Journal of Chemical Information and Modeling
https://read.qxmd.com/read/38644721/expression-and-purification-of-his-tagged-variants-of-human-hepatitis-a-virus-3c-protease
#30
JOURNAL ARTICLE
Maria A Karaseva, Vladislav A Gramma, Dina R Safina, Natalia A Lunina, Alexey A Komissarov, Sergey V Kostrov, Ilya V Demidyuk
BACKGROUND: Protease 3C (3Cpro) is the only protease encoded in the human hepatitis A virus genome and is considered a potential target for antiviral drugs due to its critical role in the viral life cycle. Additionally, 3Cpro has been identified as a potent inducer of ferroptosis, a newly described type of cell death. Therefore, studying the molecular mechanism of 3Cpro functioning can provide new insights into viral-host interaction and the biological role of ferroptosis. However, such studies require a reliable technique for producing the functionally active recombinant enzyme...
April 19, 2024: Protein and Peptide Letters
https://read.qxmd.com/read/38644719/progress-of-angiogenesis-signal-pathway-and-antiangiogenic-drugs-in-nasopharyngeal-carcinoma
#31
JOURNAL ARTICLE
Yunzhi Zhu, Yi Hu, Chengsheng Yang, Shipu Huang, Jianping Wen, Weiguo Huang, Shengjun Xiao
Nasopharyngeal cancer is a rare cancer with unique ethnic and geographic distribution. Since nasopharyngeal cancer often originates from the pharyngeal crypt, early symptoms are not obvious. They are difficult to detect in time, and the disease is usually diagnosed and treated only when it has progressed to an advanced-stage. Since angiogenesis is essential for the growth and invasion of solid tumors, antiangiogenic therapy has become a common treatment strategy for many solid tumors, and it has also achieved remarkable results in the treatment of nasopharyngeal carcinoma, which is prone to recurrence and distant metastasis...
April 19, 2024: Current Molecular Pharmacology
https://read.qxmd.com/read/38644715/1-3-4-oxadiazole-scaffold-in-antidiabetic-drug-discovery-an-overview
#32
JOURNAL ARTICLE
Ojasvi Gupta, Gita Chawla, Tathagata Pradhan
Diabetes mellitus is one of the biggest challenges for the scientific community in the 21st century. With the increasing number of cases of diabetes and drug-resistant diabetes, there is an urgent need to develop new potent molecules capable of combating this cruel disease. Medicinal chemistry concerns the discovery, development, identification, and interpretation of the mode of action of biologically active compounds at the molecular level. Oxadiazole-based derivatives have come up as a potential option for antidiabetic drug research...
April 19, 2024: Mini Reviews in Medicinal Chemistry
https://read.qxmd.com/read/38644693/chronic-neutrophilic-leukemia-and-atypical-chronic-myeloid-leukemia-2024-update-on-diagnosis-genetics-risk-stratification-and-management
#33
REVIEW
Natasha Szuber, Attilio Orazi, Ayalew Tefferi
Chronic neutrophilic leukemia (CNL) is a rare BCR::ABL1-negative myeloproliferative neoplasm (MPN) defined by persistent mature neutrophilic leukocytosis and bone marrow granulocyte hyperplasia. Atypical chronic myeloid leukemia (aCML) (myelodysplastic "[MDS]/MPN with neutrophilia" per World Health Organization [WHO]) is a MDS/MPN overlap disorder featuring dysplastic neutrophilia and circulating myeloid precursors. Both manifest with frequent hepatosplenomegaly and less commonly, bleeding, with high rates of leukemic transformation and death...
April 21, 2024: American Journal of Hematology
https://read.qxmd.com/read/38644533/transient-receptor-potential-ankyrin-1-channel-modulates-the-abuse-related-mechanisms-of-methamphetamine-through-interaction-with-dopamine-transporter
#34
JOURNAL ARTICLE
Kwang-Hyun Hur, Youyoung Lee, Audrey Lynn Donio, Seon-Kyung Kim, Bo-Ram Lee, Jee-Yeon Seo, Dooti Kundu, Kyeong-Man Kim, Stephen J Kohut, Seok-Yong Lee, Choon-Gon Jang
BACKGROUND AND PURPOSE: Methamphetamine (METH) use disorder has risen dramatically over the past decade, and there are currently no FDA-approved medications due, in part, to gaps in our understanding of the pharmacological mechanisms related to METH action in the brain. EXPERIMENTAL APPROACH: Here, we investigated whether transient receptor potential ankyrin 1 (TRPA1) mediates each of several METH abuse-related behaviours in rodents: self-administration, drug-primed reinstatement, acquisition of conditioned place preference, and hyperlocomotion...
April 21, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38644473/protac-ezh2-degrader-1-overcomes-the-resistance-of-podophyllotoxin-derivatives-in-refractory-small-cell-lung-cancer-with-leptomeningeal-metastasis
#35
JOURNAL ARTICLE
Min-Xing Shi, Xi Ding, Liang Tang, Wei-Jun Cao, Bo Su, Jie Zhang
BACKGROUND: Leptomeningeal metastasis (LM) of small cell lung cancer (SCLC) is a highly detrimental occurrence associated with severe neurological disorders, lacking effective treatment currently. Proteolysis-targeting chimeric molecules (PROTACs) may provide new therapeutic avenues for treatment of podophyllotoxin derivatives-resistant SCLC with LM, warranting further exploration. METHODS: The SCLC cell line H128 expressing luciferase were mutated by MNNG to generate H128-Mut cell line...
April 22, 2024: BMC Cancer
https://read.qxmd.com/read/38644301/-molecular-pathology-diagnosis-as-companion-diagnostics
#36
JOURNAL ARTICLE
Satoshi Fujii
As genomic medicine advances, opportunities for molecular pathology diagnosis by pathologists to be used as companion diagnostics is increasing. Pathological specimens must be useful not only for pathological diagnosis, but also for genetic testing panel and molecular pathology diagnosis. Companion diagnostics performed by pathologists uses immunohistochemical staining and fluorescence in situ hybridization to determine patient eligibility for molecular target drugs and immune checkpoint inhibitors. By accurately observing a wide variety of diagnostic criteria and performing with high precision, pathological diagnosis will become closer to therapeutic pathology...
April 2024: Gan to Kagaku Ryoho. Cancer & Chemotherapy
https://read.qxmd.com/read/38644265/-chinese-expert-consensus-on-the-analytical-validation-of-tumor-comprehensive-genomic-profiling-next-generation-sequencing-testing-2024-edition
#37
JOURNAL ARTICLE
(no author information available yet)
In hospital laboratories-developed testing is of great significance for the clinical testing products that has not been approved by the National Medical Product Administration and is urgently needed to meet clinical practice needs. With the development of cancer precision medicine in recent years, comprehensive genomic profiling (CGP) has become an important means and method for the detection of drug targets, precise molecular typing, and immunotherapy biomarkers in cancer patients. However, there is still a lack of unified understanding and consensus on clinical testing standards and application specifications for laboratory-developed testing in the hospitals...
April 23, 2024: Zhonghua Zhong Liu za Zhi [Chinese Journal of Oncology]
https://read.qxmd.com/read/38643668/application-of-covalent-modality-in-proximity-induced-drug-pharmacology-early-development-current-strategy-and-feature-directions
#38
REVIEW
Linjie Li, Song Liu, Youfu Luo
With a growing number of covalent drugs securing FDA approval as successful therapies across various indications, particularly in the realm of cancer treatment, the covalent modulating strategy is undergoing a resurgence. The renewed interest in covalent bioactive compounds has captured significant attention from both the academic and biopharmaceutical industry sectors. Covalent chemistry presents several advantages over traditional noncovalent proximity-induced drugs, including heightened potency, reduced molecular size, and the ability to target "undruggable" entities...
April 17, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38643597/drspring-graph-convolutional-network-gcn-based-drug-synergy-prediction-utilizing-drug-induced-gene-expression-profile
#39
JOURNAL ARTICLE
Jiyeon Han, Min Ji Kang, Sanghyuk Lee
Great efforts have been made over the years to identify novel drug pairs with synergistic effects. Although numerous computational approaches have been proposed to analyze diverse types of biological big data, the pharmacogenomic profiles, presumably the most direct proxy of drug effects, have been rarely used due to the data sparsity problem. In this study, we developed a composite deep-learning-based model that predicts the drug synergy effect utilizing pharmacogenomic profiles as well as molecular properties...
April 8, 2024: Computers in Biology and Medicine
https://read.qxmd.com/read/38643561/label-free-cell-phenotypic-profiling-of-histamine-h4r-receptor-and-discovery-of-non-competitive-h4r-antagonist-from-natural-products
#40
JOURNAL ARTICLE
Hongming Tang, Tao Hou, Han Zhou, Han Liao, Fangfang Xu, Xiaomin Xie, Wenjie Yuan, Zhixin Guo, Yanfang Liu, Jixia Wang, Weijia Zhou, Xinmiao Liang
Histamine 4 receptor (H4R), the most recently identified subtype of histamine receptor, primarily induces inflammatory reactions upon activation. Several H4R antagonists have been developed for the treatment of inflammatory bowel disease (IBD) and atopic dermatitis (AD), but their use has been limited by adverse side effects, such as a short half-life and toxicity. Natural products, as an important source of anti-inflammatory agents, offer minimal side effects and reduced toxicity. This work aimed to identify novel H4R antagonists from natural products...
April 18, 2024: Bioorganic Chemistry
keyword
keyword
62682
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.